Echocardiographic changes in patients with malignant phase hypertension

The West Birmingham malignant hypertension register

S. Nadar, D. G. Beevers, G. Y H Lip

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

In order to study the echocardiographic abnormalities in consecutive patients with malignant phase hypertension (MHT), we reviewed echocardiograms of 31 patients (23 male; mean age 52±14 years) with MHT who were admitted to our unit. Trans-thoracic echocardiography was carried out in all patients, and echocardiographic measurements were compared with those of 39 patients (30 male; mean age 54±10 years with controlled nonmalignant essential hypertension, and 32 (19 male; mean age 51 ± 10 years) healthy normotensive volunteers. Patients with MHT had a significantly higher mean systolic and diastolic blood pressure (P<0.001) compared to the other two groups. MHT patients had significantly greater mean left atrial dimensions (P=0.002), as well as aortic root dimensions (P=0.01) and left ventricular (LV) dimensions (with the exception of the diastolic internal diameter) (P<0.001). MHT patients also had a mean larger LV mass and LV mass index (both P<0.001) when compared to the other two groups. The mean ejection fraction was also lower in the MHT group (P<0.001). In conclusion, patients with MHT have significant cardiac hypertrophy, in association with systolic dysfunction and dilated left atria, irrespective of the duration of known hypertension. These abnormalities may predispose MHT patients to cardiovascular complications including heart failure and cardiac arrhythmias, such as atrial fibrillation.

Original languageEnglish
Pages (from-to)69-75
Number of pages7
JournalJournal of Human Hypertension
Volume19
Issue number1
DOIs
Publication statusPublished - Jan 2005

Fingerprint

Malignant Hypertension
Blood Pressure
Cardiomegaly
Heart Atria
Atrial Fibrillation
Echocardiography
Cardiac Arrhythmias
Healthy Volunteers
Thorax
Heart Failure
Hypertension

Keywords

  • Echocardiography
  • Malignant hypertension

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Echocardiographic changes in patients with malignant phase hypertension : The West Birmingham malignant hypertension register. / Nadar, S.; Beevers, D. G.; Lip, G. Y H.

In: Journal of Human Hypertension, Vol. 19, No. 1, 01.2005, p. 69-75.

Research output: Contribution to journalArticle

@article{99ae3ff861e241b2b688e797363ec0a9,
title = "Echocardiographic changes in patients with malignant phase hypertension: The West Birmingham malignant hypertension register",
abstract = "In order to study the echocardiographic abnormalities in consecutive patients with malignant phase hypertension (MHT), we reviewed echocardiograms of 31 patients (23 male; mean age 52±14 years) with MHT who were admitted to our unit. Trans-thoracic echocardiography was carried out in all patients, and echocardiographic measurements were compared with those of 39 patients (30 male; mean age 54±10 years with controlled nonmalignant essential hypertension, and 32 (19 male; mean age 51 ± 10 years) healthy normotensive volunteers. Patients with MHT had a significantly higher mean systolic and diastolic blood pressure (P<0.001) compared to the other two groups. MHT patients had significantly greater mean left atrial dimensions (P=0.002), as well as aortic root dimensions (P=0.01) and left ventricular (LV) dimensions (with the exception of the diastolic internal diameter) (P<0.001). MHT patients also had a mean larger LV mass and LV mass index (both P<0.001) when compared to the other two groups. The mean ejection fraction was also lower in the MHT group (P<0.001). In conclusion, patients with MHT have significant cardiac hypertrophy, in association with systolic dysfunction and dilated left atria, irrespective of the duration of known hypertension. These abnormalities may predispose MHT patients to cardiovascular complications including heart failure and cardiac arrhythmias, such as atrial fibrillation.",
keywords = "Echocardiography, Malignant hypertension",
author = "S. Nadar and Beevers, {D. G.} and Lip, {G. Y H}",
year = "2005",
month = "1",
doi = "10.1038/sj.jhh.1001773",
language = "English",
volume = "19",
pages = "69--75",
journal = "Journal of Human Hypertension",
issn = "0950-9240",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Echocardiographic changes in patients with malignant phase hypertension

T2 - The West Birmingham malignant hypertension register

AU - Nadar, S.

AU - Beevers, D. G.

AU - Lip, G. Y H

PY - 2005/1

Y1 - 2005/1

N2 - In order to study the echocardiographic abnormalities in consecutive patients with malignant phase hypertension (MHT), we reviewed echocardiograms of 31 patients (23 male; mean age 52±14 years) with MHT who were admitted to our unit. Trans-thoracic echocardiography was carried out in all patients, and echocardiographic measurements were compared with those of 39 patients (30 male; mean age 54±10 years with controlled nonmalignant essential hypertension, and 32 (19 male; mean age 51 ± 10 years) healthy normotensive volunteers. Patients with MHT had a significantly higher mean systolic and diastolic blood pressure (P<0.001) compared to the other two groups. MHT patients had significantly greater mean left atrial dimensions (P=0.002), as well as aortic root dimensions (P=0.01) and left ventricular (LV) dimensions (with the exception of the diastolic internal diameter) (P<0.001). MHT patients also had a mean larger LV mass and LV mass index (both P<0.001) when compared to the other two groups. The mean ejection fraction was also lower in the MHT group (P<0.001). In conclusion, patients with MHT have significant cardiac hypertrophy, in association with systolic dysfunction and dilated left atria, irrespective of the duration of known hypertension. These abnormalities may predispose MHT patients to cardiovascular complications including heart failure and cardiac arrhythmias, such as atrial fibrillation.

AB - In order to study the echocardiographic abnormalities in consecutive patients with malignant phase hypertension (MHT), we reviewed echocardiograms of 31 patients (23 male; mean age 52±14 years) with MHT who were admitted to our unit. Trans-thoracic echocardiography was carried out in all patients, and echocardiographic measurements were compared with those of 39 patients (30 male; mean age 54±10 years with controlled nonmalignant essential hypertension, and 32 (19 male; mean age 51 ± 10 years) healthy normotensive volunteers. Patients with MHT had a significantly higher mean systolic and diastolic blood pressure (P<0.001) compared to the other two groups. MHT patients had significantly greater mean left atrial dimensions (P=0.002), as well as aortic root dimensions (P=0.01) and left ventricular (LV) dimensions (with the exception of the diastolic internal diameter) (P<0.001). MHT patients also had a mean larger LV mass and LV mass index (both P<0.001) when compared to the other two groups. The mean ejection fraction was also lower in the MHT group (P<0.001). In conclusion, patients with MHT have significant cardiac hypertrophy, in association with systolic dysfunction and dilated left atria, irrespective of the duration of known hypertension. These abnormalities may predispose MHT patients to cardiovascular complications including heart failure and cardiac arrhythmias, such as atrial fibrillation.

KW - Echocardiography

KW - Malignant hypertension

UR - http://www.scopus.com/inward/record.url?scp=12744280979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12744280979&partnerID=8YFLogxK

U2 - 10.1038/sj.jhh.1001773

DO - 10.1038/sj.jhh.1001773

M3 - Article

VL - 19

SP - 69

EP - 75

JO - Journal of Human Hypertension

JF - Journal of Human Hypertension

SN - 0950-9240

IS - 1

ER -